It also enlightens us that in the future, we can consider building a prediction model of tumour radiotherapy response and RILI based on ALKBH5/TIRAP regulatory axis genes and designing relevant targeted therapy strategies rather than simply based on ALKBH5 expression. This evidence concerns the gene TIRAP and neoplasm.